Biohaven (BHVN) Assets Average (2022 - 2026)
Biohaven (BHVN) reported Assets Average of $458.9 million for Q1 2026, down 14.54% on a YoY basis from $537.0 million in Q1 2025, and up 6.66% sequentially from $430.3 million in Q4 2025.
Biohaven (BHVN) Assets Average (2022 - 2026) Analysis & Trends
Biohaven (BHVN) has 5 years of Assets Average data on file, last reported at $458.9 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 14.54% year-over-year to $458.9 million; the trailing twelve-month figure through Mar 2026 stood at $458.9 million (down 14.54% YoY), and the FY2025 full-year result was $533.3 million, down 5.47% from the prior year.
- Assets Average rose to $458.9 million in Q1 2026, from $430.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $640.2 million in Q1 2023 to a low of $398.7 million in Q4 2022.
- A 5-year average of $498.6 million and a median of $490.2 million in 2024 frame the typical range for Assets Average.
- Peak annual rise in Assets Average reached 25.64% in 2024, while the deepest fall reached 27.22% in 2024.
- Tracing BHVN's Assets Average over 5 years: stood at $398.7 million in 2022, then gained by 12.35% to $448.0 million in 2023, then grew by 25.64% to $562.8 million in 2024, then declined by 23.55% to $430.3 million in 2025, then gained by 6.66% to $458.9 million in 2026.
- Business Quant data shows BHVN's Assets Average at $458.9 million in Q1 2026, $430.3 million in Q4 2025, and $479.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 458.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458.93 Mn |
| Dec 31, 2025 | 430.29 Mn |
| Sep 30, 2025 | 479.77 Mn |
| Jun 30, 2025 | 504.68 Mn |
| Mar 31, 2025 | 537.03 Mn |
| Dec 31, 2024 | 562.82 Mn |
| Sep 30, 2024 | 546.58 Mn |
| Jun 30, 2024 | 500.59 Mn |
| Mar 31, 2024 | 465.87 Mn |
| Dec 31, 2023 | 447.97 Mn |
| Sep 30, 2023 | 444.74 Mn |
| Jun 30, 2023 | 562.63 Mn |
| Mar 31, 2023 | 640.15 Mn |
| Dec 31, 2022 | 398.71 Mn |